Engineering Single-Signal Activated TILs with CD3Z-CD28 Chimeras for Potent Antitumor Activity in Solid Tumors
This study investigates signaling responses in wild-type (WT) Jurkat cells and engineered OSA-Jurkat cells (M2 and M7 types) under basal and activated conditions.